BioCentury
ARTICLE | Clinical News

PF-04449913: Phase I data

September 28, 2015 7:00 AM UTC

An open-label, U.S. and Italian Phase I trial in 47 patients with acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia, myelodysplastic syndrome (MDS) ...